Editorial Policy

The Female Biohacker publishes evidence-led decision support for women navigating perimenopause, menopause, metabolic health, strength, performance and emerging therapies.

Answer the reader’s real question

Every substantive guide defines its intent, gives a concise answer, explains which population and outcome the evidence covers, then shows limits, safety context, practical segmentation and related paths. Search demand may identify a question; it does not decide the answer.

Source and claim discipline

Material health claims require an identifiable source, population, intervention or exposure, outcome and limitation. Mechanisms, animal research, observational findings, trials, guidelines and regulatory records are labeled distinctly. Inaccessible details are not inferred.

AI and human roles

AI may organize public research, reopen accessible sources, prepare prose, test interfaces and flag uncertainty. It cannot supply lived experience, credentials, medical approval, legal advice, product testing or final editorial judgment. Those claims appear only when real and documented.

Commercial independence

Commission or program eligibility cannot determine inclusion, rank or health conclusions. Any future paid relationship must be disclosed before the first compensated link and technically qualified. Unapproved investigational drugs receive regulatory and risk education, never transaction pathways.

Corrections and updates

Material source, safety, regulatory and product-status claims carry dated checks and update triggers. Corrections preserve a concise change record and prioritize accuracy over prior wording or search performance.